Literature DB >> 10336727

Characterization of 17beta-hydroxysteroid dehydrogenase activity in brain tissue: testosterone formation in the human temporal lobe.

S Steckelbroeck1, B Stoffel-Wagner, R Reichelt, J Schramm, F Bidlingmaier, L Siekmann, D Klingmüller.   

Abstract

Sex steroids exert important effects on the central nervous system (CNS). Although the formation of 17beta-hydroxysteroid dehydrogenase (17beta-HSD) metabolites in the CNS was discovered almost 30 years ago, conclusive studies concerning 17beta-HSD activity in the human brain are still lacking. Therefore, we investigated 17beta-HSD in vitro activity in human temporal lobe biopsies of 13 women and 13 men using radioactively labelled androstenedione, testosterone, oestrone and 17beta-oestradiol and compared it to that in human placenta, liver, testis and prostate. We could demonstrate androgenic and oestrogenic 17beta-HSD activities in all tissues under investigation. The reduction of androstenedione and oestrone in brain was NADPH dependent with a broad pH optimum between 6.5 and 9.0, whereas the oxidation of testosterone and 17beta-oestradiol was NAD dependent with a pH optimum of >/=9.0. Using optimum cofactors sex differences of brain 17beta-HSD activities were not observed. Conversion of androstenedione, testosterone, oestrone and 17beta-oestradiol was significantly higher in the subcortical white matter than in the cerebral cortex. We could demonstrate a significant formation of testosterone in the brain tissue of all patients under investigation. Substrate specificity and cofactor requirement patterns as well as pH optima and kinetic properties suggest the occurrence of 17beta-HSD type 3 and type 4 in the human temporal lobe.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336727     DOI: 10.1046/j.1365-2826.1999.00363.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  5 in total

1.  Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor.

Authors:  U Hoppe; P-M Holterhus; L Wünsch; D Jocham; T Drechsler; S Thiele; C Marschke; O Hiort
Journal:  J Mol Med (Berl)       Date:  2006-03-25       Impact factor: 4.599

Review 2.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

Review 3.  Androgen replacement therapy in androgen-deficient women with hypopituitarism.

Authors:  Hong Zang; Susan R Davis
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Protective Effect of Meso-Tetrakis-(3,5-di-tert-butyl-4-hydroxyphenyl)porphyrin on the In Vivo Impact of Trimethyltin Chloride on the Antioxidative Defense System.

Authors:  Elena R Milaeva; Vladimir Yu Tyurin; Yulia A Gracheva; Margarita A Dodochova; Lydia M Pustovalova; Victor N Chernyshev
Journal:  Bioinorg Chem Appl       Date:  2006-12-27       Impact factor: 7.778

Review 5.  Steroids and Alzheimer's Disease: Changes Associated with Pathology and Therapeutic Potential.

Authors:  Yvette Akwa
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.